Succes med implantatbehandling kræver bakteriekontrol gennem hele behandlingsforløbet

Biofilm kan ophobes omkring implantater og være vanskelig at kontrollere mekanisk. Lumoral® kan anvendes som supplement til den kliniske behandling og patientens daglige mundhygiejne for at understøtte bakteriekontrol omkring implantatet.

Lumoral®

A structured implant protocol in 3 phases

The protocol uses 70 Lumorinse® tablets

1. Before implant treatment

Once daily for 14 days

Lumoral® is used daily in the period leading up to implant treatment as an adjunct to the clinical treatment and the patient’s self-care.

2. After implant treatment

Once daily for 14 days

Lumoral® is continued daily after implant treatment as an adjunct to postoperative care and the patient’s oral hygiene.

3. Aftercare and maintenance

Twice weekly for 3 months

After the initial treatment period, Lumoral® is continued twice a week to support bacterial control between clinic visits.

Then:
Twice weekly, preventively

Lumoral® products for implant treatment

The patient starts with a Lumoral® starter pack containing 10 Lumorinse® tablets, with a further 60 Lumorinse® tablets added for the full 3-month course of treatment.

Total: 70 Lumorinse® tablets.

After the course, maintenance 2 x per week is recommended

Lumoral® patient starter pack

1.393,00 DKKEx. VAT
Number of packages
Number of packages: 1 package
2025 · Randomized controlled study

40 patients with newly diagnosed peri-implant disease

The patients were randomized to either four weeks of home treatment with dual-light aPDT or improved oral self-care alone.

The results showed:

  • BOP fell from 4.7 to 1.8 in the treatment group
  • aMMP-8 fell from 100 to 72
  • The treatment group showed a greater reduction in inflammation than the control group

The study supports the potential of repeated home-based dual-light aPDT as a supplement to daily oral care in patients with peri-implant disease.

Read the randomized study from 2025

2022 · Pilot study

7 patients with peri-implant disease

The patients used Lumoral® daily for four weeks as a supplement to their normal oral hygiene.

After four weeks the following were observed:

  • ↓ plaque
  • ↓ bleeding on probing (BOP)
  • ↓ aMMP-8, an inflammation marker
  • A reduction in peri-implant pocket depth of 1 mm, which was not statistically significant

The study indicates that repeated home-based dual-light aPDT can reduce clinical signs of inflammation around implants.

Read the study from 2022

Implant protocol

Download the brochure for more detail on the points on this page.

Download the brochure in Danish Download the brochure in English

Let us help you build Lumoral® into your implant treatments!

Contact us here:

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.